London-based Samphire Neuroscience raises €2.1 million to launch wearable that targets PMS and menstrual pain
Medtech startup Samphire Neuroscience secured €2.1 million in pre-seed funding to launch Nettle, their medical-grade neurostimulation wearable.
Read the article on EU Startups >
Read More from the Global Wellness News ™